Susquehanna International Group, LLP Macrogenics Inc Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Macrogenics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 112,898 shares of MGNX stock, worth $153,541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,898
Previous 76,824
46.96%
Holding current value
$153,541
Previous $249,000
42.57%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding MGNX
# of Institutions
133Shares Held
54MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$13.5 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$8.56 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$7.35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$6.02 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$4.42 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $83.6M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...